Connection

Konstantinos Syrigos to Antigens, Differentiation, Myelomonocytic

Back to Details
This is a "connection" page, showing publications Konstantinos Syrigos has written about Antigens, Differentiation, Myelomonocytic.
Konstantinos Syrigos
Connection Strength
0.091
Antigens, Differentiation, Myelomonocytic
  1. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
    View in: PubMed
    Score: 0.051
  2. Spatially Resolved and Quantitative Analysis of VISTA/PD-1H as a Novel Immunotherapy Target in Human Non-Small Cell Lung Cancer. Clin Cancer Res. 2018 04 01; 24(7):1562-1573.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.